Despite the widespread acceptance and high success rate of shock-wave lithotripsy (SWL) for urinary stones, some calculi are found to be partially or completely resistant, requiring ancillary procedures with additional costs[@b1]. Several stone characteristics including stone size, mean stone density (MSD), and skin-to-stone distance (SSD) have been suggested to optimize and predict SWL outcomes.

MSD is well-known as a potentially useful independent predictor of SWL outcomes[@b2][@b3][@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b13]. MSD is the mean value of the Hounsfield units (HUs) of each pixel in a certain stone area that can be easily determined from non-contrast computed tomography (NCCT) using a picture archiving and communication system (PACS)[@b14]. Generally, a PACS can also provide additional pixel statistics such as the minimum, maximum, and standard deviation of HU values. In statistics, the standard deviation is a measure that is used to quantify the amount of variation or dispersion of a set of data values, and a high standard deviation indicates that the data points are spread out over a wider range of values. Similarly, a high standard deviation of HUs may suggest heterogeneity in stone composition.

As shown in [Fig. 1](#f1){ref-type="fig"}, because the composition of urinary stones can vary even though they have a similar MSD, we postulated that a heterogeneous stone may be more fragile than a homogeneous stone. Herein, we defined the stone heterogeneity index (SHI) as the standard deviation of stone density on NCCT, and investigated whether SHI can be a novel predictor for SWL outcomes in patients with ureteral stones.

Results
=======

Demographic analysis
--------------------

The mean age of total patients was 51.92 ± 14.50 years. The distribution of ureteral stone locations was comprised of 492 cases of upper ureter stones (81.5%), 42 cases of mid-ureter stones (7.0%), and 70 cases of lower ureter stones (11.5%). The mean stone size was 9.12 ± 3.89 mm, and the mean MSD and SHI were 710.25 ± 269.65 HU and 229.45 ± 99.62 HU, respectively. The mean SSD was 109.96 ± 19.31 mm. The one-session success and one-session stone-free rates were 68.9% and 66.2%, respectively ([Table 1](#t1){ref-type="table"}).

Comparison between the low and high SHI groups
----------------------------------------------

All patients were divided into low and high SHI groups according to the mean SHI. In terms of age, sex, stone location, size, and SSD, there was no significant difference between the two groups. MSD was significantly higher in the high SHI group than in the low SHI group (817.80 ± 247.02 HU vs. 612.23 ± 251.76 HU, P \< 0.001). Nevertheless, the one-session success and stone-free rates in the high SHI group were higher than in the low SHI group (74.3% vs. 63.9%, P = 0.008 in one-session success rate; 70.5% vs. 62.3%, P = 0.043 in one-session stone-free rate; [Table 1](#t1){ref-type="table"}).

Factors affecting the one-session success and stone-free status
---------------------------------------------------------------

Univariate and multivariate logistic regression models were generated for one-session success and stone-free status. The multivariate model revealed that smaller stone size (OR 0.889, 95% Confidence Interval \[CI\]: 0.841--0.937, P \< 0.001), lower MSD (OR 0.995, 95% CI: 0.994--0.996, P \< 0.001), and higher SHI (OR 1.011, 95% CI: 1.008--1.014, P \< 0.001) were independent predictors of one-session success. Similarly, stone size (OR 0.886, 95% CI: 0.839--0.933, P \< 0.001), MSD (OR 0.996, 95% CI: 0.995--0.997, P \< 0.001), and SHI (OR 1.008, 95% CI: 1.005--1.010, P \< 0.001) also had an independent impact on one-session stone-free status ([Table 2](#t2){ref-type="table"}).

Impact of SHI on SWL outcomes according to stone size and MSD
-------------------------------------------------------------

In patients with a stone size ≥10 mm, the one-session success rate was 50.2%, and SHI was significantly different between those with success and failure (279.92 ± 115.66 HU vs. 204.99 ± 85.85 HU, P \< 0.001). However, there was no difference in SHI according to the success or failure in patients with a stone size \< 10 mm ([Table 3](#t3){ref-type="table"}). Meanwhile, one-session success rates were 75.0% in patients with a MSD \< 1000 HU versus 38.0% in patients with a MSD ≥ 1000 HU. In patients with a MSD ≥ 1000 HU, SHI was significantly higher in cases with one-session success than in the cases with failure (308.02 ± 91.87 HU vs. 251.48 ± 54.51 HU, P = 0.001; [Table 4](#t4){ref-type="table"}).

Discussion
==========

In the current study, we introduced the concept of radiologic heterogeneity of a urinary stone based on a HU measurement in NCCT and demonstrated the clinical significance of SHI in the management of patients with a ureteral stone. To the best of our knowledge, this is the first report dealing with this novel clinical factor, and we revealed that SHI was an independent predictor of SWL outcomes in ureteral stones. In general, urinary stones with a larger stone size (i.e., \>10 mm) or a higher MSD (i.e., \>1000 HU) have been deemed to be resistant to SWL, and stone size seems to be the most influential factor in predicting SWL outcomes[@b1][@b15]. Our results are in agreement with prior studies. Nevertheless, in certain stones with a higher SHI, favorable outcomes can be expected even though a stone may possess conventionally unfavorable clinical features, such as a larger stone size or a higher MSD ([Tables 3](#t3){ref-type="table"} and [4](#t4){ref-type="table"}). We believe that SHI can be a useful clinical parameter for stone fragility and can play a complementary role for such a clinical prediction in addition to stone size and MSD. In addition, SHI can be readily measured using the currently available PACS without additional equipment.

MSD has been widely used during the last decade as an important parameter to characterize urinary stones for both research and clinical practice[@b16]. However, MSD is only an arithmetical average that cannot represent the heterogeneity of stone composition, as shown in [Fig. 1](#f1){ref-type="fig"}. Conversely, the standard deviation of a random variable, statistical population, data set, or probability distribution is the square root of its variance. SHI is an index presenting the radiological heterogeneity of a urinary stone defined as the standard deviation of HU in the region of interest, as aforementioned. Accordingly, SHI can represent the internal diversity of a stone, reflecting not only the heterogeneity of the stone's composition but also the structural and morphological heterogeneity of a stone. There can be several explanations for the difference in SHI of urinary stones. First, urinary stones are generally not monocrystals, which can be a cause for SHI. Jing *et al.* reported a prospective analysis of urinary calculi composition by infrared spectroscopy with 625 patients in eastern China[@b17]. They showed that 37.4% of urinary stones are pure stones, but most urinary stones were mixed (62.6%) in which calcium oxalate was the most commonly found major component. Second, the internal structure and morphology of stones can vary, even though the composition of minerals is similar, which can also contribute to such differences in SHI value. Urinary stones present with a variety of gross appearances according to their contour irregularities, such as smoothly round, spiculated, and mulberry stones[@b18]. Meanwhile, the internal structure showing a heterogeneity of composition or cracks were also detected using NCCT even in stones with the same attenuation; cross-sectional images of such a stone can differ from mottled to lamellar structures[@b19]. In addition, there can be some empty space within urinary calculi structural irregularities. This space can be filled with water or air, which might be an important cause of heterogeneity of the attenuation index.

Conventionally, stone composition has been undoubtedly important in determining the efficacy of stone treatment, especially SWL. The most dramatic differences have been found with radiolucent uric acid calculi (easily fragmented with SWL) and relatively radiolucent cysteine calculi (often refractory to SWL), which is useful information in selecting stone treatment[@b20]. Accordingly, knowing the composition of urinary calculi is essential for deciding the optimal mode of treatment. Urine pH, the presence of crystals, urease-positive bacteria in the urine, a plain x-ray, and a history of urinary stones have long been used to predict the composition of stones[@b21]. During last two decades, the relationship between HU and stone composition has been investigated. Several studies demonstrated with an *in vitro* approach that stone composition could be predicted with high accuracy using HU and HU density (HU divided by the greatest transverse diameter)[@b22][@b23][@b24]. However, Toricelli *et al.* showed that there was an overlap between the HU values of cysteine and uric acid stones, making it difficult to differentiate these types of stones[@b25]. Such an overlap of values also precludes any more exact determination of stone composition by the MSD. In 2003, Williams *et al.* suggested that knowing the major composition of a stone may not allow adequate prediction of its fragility in lithotripsy treatment, and variations in internal stone structure, including secondary mineral composition, may be a significant cause of this variability in stone fragility[@b26].

The relationship between CT parameters and SWL outcomes has also been extensively investigated, and representative studies are summarized in [Table 5](#t5){ref-type="table"}. In the NCCT era of urinary stone management, lots of interest has been raised about MSD and SSD as novel predictors of SWL outcomes. Most studies showed that MSD was significantly associated with SWL success, but only two studies showed no relationship between MSD and SWL outcomes[@b27][@b28]. El-Nahas showed that a MSD \> 1000 HU was a significant independent predictor of SWL failure. Thus, they maintained that an alternative treatment should be offered for patients with a MSD \> 1000 HU[@b5]. Interestingly, in cases with a MSD \> 1000 HU, the success or stone-free groups demonstrated significantly higher SHIs than the failure group in our study ([Table 4](#t4){ref-type="table"}). However, the role of SSD as a predictor of SWL success remains controversial. Approximately half of the published studies have advocated the role of SSD in predicting SWL outcomes, but the other studies have failed to demonstrate a significant relationship between SSD and SWL success.

This study has some inherent limitations due to its retrospective design, which may have introduced sampling bias; however, we built a relatively large cohort for ureteral stone disease. In addition, to overcome this type of limitation, subjects of our study were only ureters stones to elucidate the impact of SHI on SWL outcomes more clearly. In renal stone, anatomical considerations including location of calyx and renal pelvic stone or infundibulopelvic angle can be another bias. Two different generating machines may be a bias, but there were no statistical difference in each period. Another concern is that the clinical significance of SHI may be limited due to its OR from the logistic regression analysis, which may be a major obstacle to using SHI in a clinical setting. However, multivariate analysis demonstrated that the predictive power for treatment outcomes was in order of stone size, SHI, and MSD based on odds ratios ([Table 2](#t2){ref-type="table"}). In addition, SHI was a significant predictor for successful outcomes in patients with stone sizes of ≥10 mm ([Table 3](#t3){ref-type="table"}), and there was a significant difference in SHI between success and failure groups regardless of MSD ([Table 4](#t4){ref-type="table"}). Meanwhile, the relationship among stone size, MSD, and SHI is a very important and interesting issue. Correlation analyses demonstrated no relationship between stone size and SHI (r = 0.060; P = 0.114) while showing a positive correlation between stone size and MSD (r = 0.317; P \< 0.001). Taken together, although the predictive power of SHI seems to be limited and weaker than stone size, SHI can play a complementary role in the prediction of treatment outcomes, similar to MSD.

However, further studies with a prospective design are needed to confirm our observation on the relationship between SHI and SWL outcomes, and a clinically applicable cut-off value of SHI should be determined for the selection of proper candidates for SWL treatment. In addition, experimental studies in conjunction with chemical and structural analysis of urinary calculi would be helpful for a thorough understanding of the clinical significance of SHI.

In summary, the radiologic heterogeneity of a urinary stone or SHI was independently associated with SWL success in patients with ureteral calculi, thus SHI can be a useful clinical parameter for stone fragility. SHI may be affected by the compositional heterogeneity in urinary calculi, as well as their structural and morphological heterogeneity. SHI will play a promising role when determining a treatment modality in patients with a urinary stone, and especially when selecting the proper SWL candidates from the patients with a stone of large size or high MSD.

Methods
=======

Patient cohort
--------------

Medical records were obtained from a consecutive database of patients who had undergone the first session of SWL between November 2005 and December 2013 in the Severance Hospital, Seoul, Korea. During this period, a total of 1,519 patients were registered in our database. Inclusion criteria for the current study were a 4- to 20-mm stone in the ureter and radiopaque calculi on a plain x-ray. Patients who did not undergo a NCCT scan were excluded. Ultimately, 604 patients with ureter calculi were eligible for the current analyses. The Institutional Review Board of Severance Hospital approved this study protocol (Approval No. 4-2014-0465).

Shock-wave lithotripsy
----------------------

SWL was performed with an electroconductive lithotripter (EDAP Sonolith Praktis, Technomed, Lyon, France) until 2011; after 2012, the device was replaced by an electromagnetic generative lithotripter (Dornier Compact Delta II lithotripter, Dornier MedTech GmbH, Wessling, Germany). All patients were treated under fluoroscopic guidance. The number of shock waves per SWL session varied from 2500 to 4000 at a rate of 60 to 90 shock waves per minute with a launch intensity ranging from 16 to 55 MPa.

Stone characteristics on non-contrast computed tomography
---------------------------------------------------------

Stone characteristics include the location, size, SSD, MSD, and SHI. We used the GE Centricity system (GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA) during the measurement procedure. The stone size was determined from the largest stone diameter on the axial or coronal plane of NCCT, and the SSD measurement was taken from the point of the largest stone diameter at a 45° angle from the horizontal. HU was measured on the magnified, axial NCCT image from the point of the largest stone diameter, where the elliptical region of interest incorporated the largest cross-sectional area of the stone without including the adjacent soft tissue. MSD was defined as the mean value of HU in the region of interest, and SHI was defined as the standard deviation of HU in the same region of interest ([Fig. 2](#f2){ref-type="fig"}). A successful SWL treatment of ureteral and renal calculi was defined as those patients who were rendered stone-free or had asymptomatic, clinically insignificant residual fragments ≤3 mm in the largest stone diameter 2 weeks after a single SWL treatment[@b29], as measured by a simple x-ray without the need for auxiliary measures within a 3-month follow-up period. Stone-free status was defined as when a simple X-ray analysis determined that patients had a calcification-free 2-week period after a single SWL treatment.

Statistical analysis
--------------------

Statistical comparisons of continuous variables from the patient demographic information were carried out using either a Student's or Welch's two-sample t-test or the Wilcoxon rank-sum test. Categorical variables were compared using Pearson's chi-squared test. Univariate and multivariate logistic regressions with a binomial method were carried out for significant factors of one-session success and stone-free status. Statistical analyses were performed using R software (version 3.0.3, R Foundation for Statistical Computing, Vienna, Austria; <http://www.r-project.org>).
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![Schematic diagram showing the compositional heterogeneity of urinary calculi.\
All three stones demonstrate the same mean stone density (MSD) of 900 HU but their stone heterogeneity index (SHI) is different.](srep23988-f1){#f1}

![Measurement of stone heterogeneity index (SHI) on axial images of non-contrast computed tomography (NCCT).\
(**A**) Soft tissue setting view, (**B**) Bone setting view (Mean stone density = 807.2 HU and Stone heterogeneity index = 255.4 HU).](srep23988-f2){#f2}

###### Clinical data on total patients and patients with low and high stone heterogeneity indices.

                                Total patients      Low SHI^a^        High SHI^a^      P-Value
  ---------------------------- ----------------- ----------------- ----------------- ------------
  No. of patients                     604               316               288              
  Sex (M:F)                         394:210           204:112           190:98         0.780^b^
  Mean Age (yrs)                 51.92 ± 14.50     52.17 ± 14.92     51.65 ± 14.05     0.663^c^
  Location (%)                                                                         0.103^b^
   Upper                          492 (81.5)        250 (79.1)        242 (84.0)          --
   Mid                             42 (7.0)          21 (6.6)          21 (7.3)           --
   Lower                           70 (11.5)         45 (14.3)         25 (8.7)           --
  Stone size (mm)                 9.12 ± 3.89       9.04 ± 4.56       9.21 ± 3.00      0.567^c^
  SSD (mm)                      109.96 ± 19.31    110.10 ± 19.94    109.80 ± 18.63     0.850^c^
  MSD (HU)                      710.25 ± 269.65   612.23 ± 251.76   817.80 ± 247.02   \<0.001^c^
  SHI (HU)                      229.45 ± 99.62    155.50 ± 51.95    310.58 ± 72.54    \<0.001^c^
  One-session success (%)         416 (68.9)        202 (63.9)        214 (74.3)       0.008^b^
  One-session stone-free (%)      400 (66.2)        197 (62.3)        203 (70.5)       0.043^b^

SSD: skin-to-stone distance, MSD: mean stone density, SHI: stone heterogeneity index.

^a^Low and high SHI groups were divided using mean SHI (229.45).

^b^Pearson's Chi-squared test with Yates' continuity correction.

^c^Student's or Welch's two-sample t-test.

###### Univariate and multivariate logistic regression models^a^ on one-session success and stone-free status in total patients with a ureteral stone.

                             Univariate   Multivariate                                   
  ------------------------- ------------ -------------- --------- ------- -------------- ---------
  One-session success                                                                    
   Age (year)                  0.995      0.983--1.007    0.394                               
   Sex (Male)                  0.831      0.574--1.195    0.323                               
   Stone size (mm)             0.832      0.789--0.874   \<0.001   0.889   0.841--0.937   \<0.001
   SSD (mm)                    0.999      0.990--1.008    0.769                               
   MSD (HU)                    0.997      0.996--0.998   \<0.001   0.995   0.994--0.996   \<0.001
   SHI (HU)                    1.004      1.002--1.005   \<0.001   1.011   1.008--1.014   \<0.001
  One--session stone-free                                                                
   Age (year)                  0.991      0.979--1.003    0.128                               
   Sex (Male)                  0.822      0.573--1.174    0.285                               
   Stone size (mm)             0.832      0.790--0.875   \<0.001   0.886   0.839--0.933   \<0.001
   SSD (mm)                    1.000      0.991--1.008    0.992                               
   MSD (HU)                    0.997      0.996--0.998   \<0.001   0.996   0.995--0.997   \<0.001
   SHI (HU)                    1.002      1.000--1.004    0.017    1.008   1.005--1.010   \<0.001

SSD: skin-to-stone distance, MSD: mean stone density, SHI: stone heterogeneity index.

^a^A multivariate logistic regression model with forward stepwise selection was performed.

###### Comparison of stone heterogeneity index (SHI) in one-session success and stone-free status according to stone size.

                                    N (%)         SHI (HU)         P-value\*     
  ------------------------------ ------------ ---------------- ----------------- ---------
  Stone size ≥10 mm (N = 229)                                                    
  One-session success                Yes         115 (50.2)     279.92 ± 115.66   \<0.001
  No                              114 (49.8)   204.99 ± 85.85                    
  One-session stone-free             Yes         109 (47.6)     274.62 ± 113.76   \<0.001
  No                              120 (52.4)   213.54 ± 94.76                    
  Stone size \<10 mm (N = 375)                                                   
  One-session success                Yes         301 (80.3)     224.15 ± 102.60    0.180
  No                              74 (19.7)    210.23 ± 78.89                    
  One-session stone-free             Yes         291 (77.6)     221.43 ± 100.22    0.991
  No                              84 (22.4)    221.31 ± 84.30                    

SHI: stone heterogeneity index.

\*Student's two-sample t-test for stone heterogeneity index in each group.

###### Comparison of stone heterogeneity index (SHI) in one-session success and stone-free status according to mean stone density.

                                N (%)         SHI (HU)         P-value\*     
  -------------------------- ------------ ---------------- ----------------- ---------
  MSD ≥ 1000 HU (N = 100)                                                    
  One-session success            Yes         38 (38.0)      308.02 ± 91.87     0.001
  No                          62 (62.0)    251.48 ± 54.51                    
  One-session stone-free         Yes         36 (36.0)      299.45 ± 87.65     0.016
  No                          64 (64.0)    258.07 ± 64.30                    
  MSD \< 1000 HU (N = 504)                                                   
  One-session success            Yes         378 (75.0)     232.69 ± 109.81   \<0.001
  No                          126 (25.0)   185.19 ± 95.89                    
  One-session stone-free         Yes         364 (72.2)     229.64 ± 106.64    0.001
  No                          140 (27.8)   197.85 ± 98.55                    

MSD: mean stone density, SHI: stone heterogeneity index.

\*Student's two-sample t-test for stone heterogeneity index in each group.

###### Review of the literature on the relationship between stone characteristics and shock-wave lithotripsy outcomes.

  Reference                    Year    Country    Size  Stone location                  MSD (HU)         SSD (mm)      Predictors of success treatment  
  --------------------------- ------ ----------- ------ --------------------------- ---------------- ---------------- --------------------------------- -----
  Pareek *et al.*[@b27]        2005      USA       64   Lower calyx                    660/950^b^     81.2/115.3^b^                  No                  Yes
  Gupta *et al.*[@b2]          2005     India     112   Renal and proximal ureter          --               --                       Yes                 --
  Yoshida *et al.*[@b3]        2006     Japan      62   Renal and proximal ureter      562/742^a^           --                       Yes                 --
  Perks *et al.*[@b4]          2007    Canada      76   Renal and ureter              684/1034^a^           --                       Yes                 --
  El-Nahas *et al.*[@b5]       2007     Egypt     120   Renal                          709/776^a^       91/117^a^                    Yes                 No
  Weld *et al.*[@b6]           2007      USA      200   Renal                          662/728^a^       106/106^a^                   Yes                 No
  Perks *et al.*[@b7]          2008    Canada     111   Renal                         801/1092^a^       100/111^a^                   Yes                 Yes
  Kacker *et al.*[@b8]         2008      USA      325   Renal and ureter                522/724             --                       Yes                 --
  Jacobs *et al.*[@b30]        2008      USA       85   Renal and ureter             692.9/812.4^c^   103.9/101.0^c^                 --                  No
  Bandi *et al.*[@b9]          2008      USA       94   Renal and ureter               475/544^d^     108.5/102.9^d^                 Yes                 No
  Ng *et al.*[@b10]            2009   Hong Kong    94   Proximal ureter                534/626^a^     102.3/104.4^a^                 Yes                 Yes
  Patel *et al.*[@b28]         2009      USA       83   Renal                        787.7/803.2^e^   83.3/107.7^e^                  No                  Yes
  Wiesenthal *et al.*[@b11]    2010    Canada     422   Renal and ureter                 767.2            113.6                      Yes                 Yes
  Choi *et al.*[@b12]          2012     Korea     153   Ureter                       756.5/833.8^f^   103.2/101.0^f^                 Yes                 No
  Tanaka *et al.*[@b13]        2013     Japan      75   Renal and ureter                 670.3             104                       Yes                 No
  Present                      2014     Korea     604   Ureter                           710.3             110                       Yes                 No

^a^Success group vs. failure group.

^b^Stone-free *vs.* residual stone (p \< 0.05 in both MSD and SSD).

^c^Stone-free *vs*. residual stone (p \> 0.05 in both MSD and SSD). SSD was measured from the center of the stone to the level of the skin at 30°.

^d^Stone-free *vs.* residual stone (p \> 0.05 in both MSD and SSD).

^e^Stone-free *vs.* residual stone (p \> 0.05 in MSD and p \< 0.05 in SSD).

^f^Stone size ≤10 mm *vs.* \>10 mm.
